Free Trial

Bruker (BRKR) Competitors

$72.44
-3.42 (-4.51%)
(As of 10:28 AM ET)

BRKR vs. PKI, AVTR, TXG, A, MTD, WAT, ILMN, TECH, CRL, and BIO

Should you be buying Bruker stock or one of its competitors? The main competitors of Bruker include Revvity (PKI), Avantor (AVTR), 10x Genomics (TXG), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), and Bio-Rad Laboratories (BIO).

Bruker vs.

Bruker (NASDAQ:BRKR) and Revvity (NYSE:PKI) are both large-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, community ranking, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

Bruker pays an annual dividend of $0.20 per share and has a dividend yield of 0.3%. Revvity pays an annual dividend of $0.28 per share. Bruker pays out 7.3% of its earnings in the form of a dividend. Revvity pays out 3.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Bruker received 167 more outperform votes than Revvity when rated by MarketBeat users. Likewise, 64.82% of users gave Bruker an outperform vote while only 60.24% of users gave Revvity an outperform vote.

CompanyUnderperformOutperform
BrukerOutperform Votes
667
64.82%
Underperform Votes
362
35.18%
RevvityOutperform Votes
500
60.24%
Underperform Votes
330
39.76%

In the previous week, Bruker had 14 more articles in the media than Revvity. MarketBeat recorded 14 mentions for Bruker and 0 mentions for Revvity. Revvity's average media sentiment score of 0.73 beat Bruker's score of 0.43 indicating that Revvity is being referred to more favorably in the news media.

Company Overall Sentiment
Bruker Neutral
Revvity Positive

Bruker currently has a consensus price target of $85.00, indicating a potential upside of 12.05%. Revvity has a consensus price target of $54.00, indicating a potential upside of ∞. Given Revvity's stronger consensus rating and higher possible upside, analysts clearly believe Revvity is more favorable than Bruker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bruker
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
Revvity
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Bruker has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500. Comparatively, Revvity has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500.

79.5% of Bruker shares are owned by institutional investors. Comparatively, 85.2% of Revvity shares are owned by institutional investors. 28.3% of Bruker shares are owned by insiders. Comparatively, 0.5% of Revvity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Revvity has a net margin of 28.94% compared to Bruker's net margin of 13.38%. Bruker's return on equity of 27.31% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Bruker13.38% 27.31% 8.82%
Revvity 28.94%11.17%5.83%

Revvity has higher revenue and earnings than Bruker. Revvity is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bruker$3.00B3.67$427.20M$2.7527.59
Revvity$3.31B0.00$569.18M$7.68N/A

Summary

Bruker beats Revvity on 10 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BRKR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BRKR vs. The Competition

MetricBrukerAnalytical instruments IndustryComputer SectorNASDAQ Exchange
Market Cap$11.03B$5.40B$21.01B$8.09B
Dividend Yield0.26%0.38%2.73%3.96%
P/E Ratio27.5932.17261.5618.43
Price / Sales3.675.05539.3972.31
Price / Cash21.6238.0129.4828.77
Price / Book7.533.176.904.39
Net Income$427.20M-$10.98M$618.44M$213.55M
7 Day Performance-0.71%-0.77%-0.31%-0.80%
1 Month Performance-6.31%0.39%3.30%3.42%
1 Year Performance5.95%-26.19%28.07%7.53%

Bruker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PKI
Revvity
4.2565 of 5 stars
N/A$54.00
+∞
N/A$14.57B$3.31B15.0116,700Analyst Forecast
AVTR
Avantor
4.3803 of 5 stars
$23.72
-1.7%
$26.71
+12.6%
+14.9%$16.11B$6.97B60.8214,500Short Interest ↓
Analyst Revision
Positive News
TXG
10x Genomics
4.6718 of 5 stars
$22.70
+0.5%
$48.50
+113.7%
-57.1%$2.69B$618.73M-10.181,259Gap Down
A
Agilent Technologies
3.9637 of 5 stars
$148.21
-1.6%
$141.06
-4.8%
+23.1%$43.43B$6.83B35.2918,100Dividend Announcement
Short Interest ↓
MTD
Mettler-Toledo International
3.5204 of 5 stars
$1,455.25
-1.6%
$1,257.14
-13.6%
+7.9%$31.08B$3.79B40.8117,300Positive News
WAT
Waters
3.7422 of 5 stars
$331.84
-1.4%
$305.78
-7.9%
+27.3%$19.96B$2.96B32.577,900
ILMN
Illumina
4.6638 of 5 stars
$105.03
-1.4%
$164.65
+56.8%
-46.4%$16.73B$4.50B-12.899,300Short Interest ↑
TECH
Bio-Techne
4.0053 of 5 stars
$79.39
-1.7%
$81.00
+2.0%
-4.9%$12.51B$1.15B63.013,050
CRL
Charles River Laboratories International
4.5583 of 5 stars
$214.51
-1.2%
$255.27
+19.0%
+10.5%$11.05B$4.13B25.2421,800Short Interest ↓
BIO
Bio-Rad Laboratories
4.7842 of 5 stars
$286.09
-0.4%
$461.00
+61.1%
-24.5%$8.16B$2.67B-27.618,030Analyst Upgrade
Short Interest ↓

Related Companies and Tools

This page (NASDAQ:BRKR) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners